Dopamine regulates brain-derived neurotrophic factor (BDNF) expression in cultured embryonic mouse striatal cells

Neuroreport. 2001 May 8;12(6):1175-9. doi: 10.1097/00001756-200105080-00025.

Abstract

The differentiation of striatal GABAergic neurons coincides with the perinatal establishment of nigrostriatal dopaminergic synaptic connections. We have shown previously that dopamine stimulates the maturation of striatal GABAergic neurons. Since BDNF also regulates the development of GABAergic cells, we hypothesized that dopamine might affect striatal BDNF expression. The influence of dopamine on BDNF protein/mRNA and trkB mRNA levels was studied in neuronal and astroglia cultures of the mouse striatum. Stimulation with dopamine and a dopamine D1 receptor agonist increased BDNF mRNA and protein but not trkB mRNA in neuronal cultures. Our data indicate a potential role for dopamine in the developmental regulation of striatal BDNF expression and suggest that dopamine effects on GABAergic cells may be intertwined with BDNF action.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine / pharmacology
  • Animals
  • Brain-Derived Neurotrophic Factor / biosynthesis*
  • Brain-Derived Neurotrophic Factor / metabolism
  • Cardiotonic Agents / pharmacology*
  • Cells, Cultured
  • Corpus Striatum / drug effects*
  • Corpus Striatum / growth & development
  • Corpus Striatum / metabolism
  • Dopamine / pharmacology*
  • Dopamine Agonists / pharmacology
  • Embryo, Mammalian
  • Female
  • Male
  • Mice
  • Mice, Inbred BALB C
  • Receptor, trkB / metabolism
  • Receptors, Dopamine D1 / agonists
  • Receptors, Dopamine D1 / metabolism

Substances

  • Brain-Derived Neurotrophic Factor
  • Cardiotonic Agents
  • Dopamine Agonists
  • Receptors, Dopamine D1
  • 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine
  • Receptor, trkB
  • Dopamine